These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3727643)

  • 1. [Is there a renaissance for trapidil?].
    Mest HJ; Thomas E
    Z Gesamte Inn Med; 1986 Apr; 41(8):217-20. PubMed ID: 3727643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Modification of the isoprenaline-induced myocardial necrosis using trapidil].
    Mai I; Lampe D; Lange B
    Z Gesamte Inn Med; 1976 Sep; 31(18):759-61. PubMed ID: 1007338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effects of treatment with trapidil compared to nifedipine on physical, emotional and cognitive exercise tolerance in patients with coronary heart disease].
    Assmann I; Lehrl S; Burkard G; Strösser W
    Arzneimittelforschung; 1996 Sep; 46(9):868-74. PubMed ID: 8967905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of trapidil and propranolol on platelet aggregation and prostacyclin-thromboxane balance following acute myocardial infarction in rabbits.
    Lu XA; Ling H; Dong CR; Ouyang JP
    J Tongji Med Univ; 1988; 8(4):238-42. PubMed ID: 3249353
    [No Abstract]   [Full Text] [Related]  

  • 5. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
    Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
    Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial of platelet-derived growth factor antagonist, trapidil, in accelerated nephrotoxic nephritis in the rabbit.
    Shinkai Y; Cameron JS
    Br J Exp Pathol; 1987 Dec; 68(6):847-52. PubMed ID: 3480754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of myocardial infarct size by trapidil in anesthetized dogs.
    Yamaguchi K; Suzuki K; Niho T; Sato M; Ito C; Ohnishi H
    J Cardiovasc Pharmacol; 1983; 5(3):499-505. PubMed ID: 6191152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of ischemic heart disease with Trapidil. Observations with 4,014 patients in medical practice].
    Lohr E
    Fortschr Med; 1994 Nov; 112(31):446-50. PubMed ID: 7806127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of trapidil on left ventricular function and platelet aggregation in patients with coronary artery disease subjected to pacing.
    Kurita A; Satomura K; Kawaguchi S; Takase B; Shibuya T; Arakawa K; Mizuno K; Sugawara H; Isojima K
    Jpn Heart J; 1991 May; 32(3):287-96. PubMed ID: 1833567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchodilatory effect of trapidil in man.
    Ikeda H; Takahashi K; Sato S; Sasaki H; Ito E; Yasui S
    Arzneimittelforschung; 1984; 34(3):309-13. PubMed ID: 6539612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet and endothelial response with trapidil in patients with peripheral obliterative arteriopathy.
    Bonfardeci G; Cimminiello C; Cantini L; Arpaia G; Aloisio M; Pozzi F
    Int Angiol; 1994 Dec; 13(4):339-42. PubMed ID: 7790757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of trapidil on regional myocardial function during acute coronary occlusion in the dog.
    Takahashi M; Sasayama S; Nakamura M; Hirose K; Kawai C
    Arzneimittelforschung; 1982; 32(3):214-8. PubMed ID: 7200778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of fibroblast proliferation in vitro and of myointimal hyperplasia in vivo by the triazolopyrimidine, Trapidil.
    Tiell ML; Sussman II; Gordon PB; Saunders RN
    Artery; 1983; 12(1):33-50. PubMed ID: 6678578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcium antagonists in the treatment of coronary heart disease].
    Rafflenbeul W
    Fortschr Med; 1984 Jul; 102(27-28):718-21. PubMed ID: 6479814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The trapidil restenosis trial (STARC study): background, methods and clinical characteristics of the patient population.
    Maresta A; Balducelli M; Cantini L; Casari A; Chioin R; Fontanelli A; Monici Preti PA; Repetto S; Raffaghello S
    Clin Trials Metaanal; 1994 Apr; 29(1):31-40. PubMed ID: 10150183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral trapidil treatment of Fontaine stage II arteriosclerotic circulatory disorders of the legs--a double-blind study].
    Voigt H; Reuter W; Hofmann B; Dobberkau A
    Z Gesamte Inn Med; 1990 May; 45(10):283-7. PubMed ID: 2392858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nitroglycerin on myocardial ischemia and its clinical manifestations in severe coronary heart disease.
    Amsterdam EA; Laslett L; Rutledge JC; Zakauddin V
    Bibl Cardiol; 1985; (39):118-28. PubMed ID: 3939511
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of trapidil on cardiovascular events in patients with coronary artery disease (results from the Japan Multicenter Investigation for Cardiovascular Diseases-Mochida [JMIC-M]).
    Hirayama A; Kodama K; Yui Y; Nonogi H; Sumiyoshi T; Origasa H; Hosoda S; Kawai C;
    Am J Cardiol; 2003 Oct; 92(7):789-93. PubMed ID: 14516877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of thrombocyte spreading and the formation of thrombus-like aggregates bound with substrate by the anti-anginal agent trapidil].
    Mazurov AV; Leĭtin VL; Repin VS
    Vopr Med Khim; 1984; 30(4):110-6. PubMed ID: 6438908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelet aggregation in atherosclerotic disease after administration of lysine acetylsalicylate].
    Evangelisti GB; Faggioli F; Garagnani A; Lama G
    Minerva Cardioangiol; 1978 Jun; 26(6):447-60. PubMed ID: 673198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.